Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Virtus Lifesci Biotech Clinical Trials ETF (BBC)

Virtus Lifesci Biotech Clinical Trials ETF (BBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Virtus ETF Advisors LLC
  • Assets Under Management 11,480,000
  • Shares Outstanding, K 400
  • 60-Month Beta 1.08
Trade BBC with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.08 (0.29%)
  • Most Recent Dividend 0.082 on 12/20/23
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.05 +6.10%
on 10/02/24
29.97 -4.24%
on 09/19/24
+0.62 (+2.21%)
since 09/11/24
3-Month
25.43 +12.86%
on 08/07/24
30.27 -5.19%
on 07/16/24
+0.55 (+1.95%)
since 07/11/24
52-Week
16.88 +70.02%
on 10/27/23
31.99 -10.28%
on 03/04/24
+9.68 (+50.85%)
since 10/11/23

Most Recent Stories

More News
Pharma Stocks Look Cheap. Here's One Way to Invest.

Last year’s projected healthcare spending growth rate of 7.5% outpaced GDP growth for the first time since the pandemic. As an aging population creates more demand for medical care, it opens up opportunities...

LLY : 932.06 (+2.35%)
NVO : 120.04 (+2.14%)
BBC : 28.70 (+3.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 29.09
2nd Resistance Point 28.89
1st Resistance Point 28.80
Last Price 28.70
1st Support Level 28.51
2nd Support Level 28.31
3rd Support Level 28.22

See More

52-Week High 31.99
Last Price 28.70
Fibonacci 61.8% 26.22
Fibonacci 50% 24.43
Fibonacci 38.2% 22.65
52-Week Low 16.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar